Clinical Significance of Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway in Korean Patients with Colorectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|79|3-4|278-282

ISSN： 0030-2414

Source： Oncology, Vol.79, Iss.3-4, 2011-03, pp. : 278-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PI3K/PTEN/AKT/mTOR polymorphisms: Association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab‐docetaxel

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 4, 2015-04 ,pp. : 471-478

John Wiley & Sons Inc

Access to resources Recommend Favorite

Signaling Intermediates (PI3K/PTEN/AKT/mTOR and RAF/MEK/ERK Pathways) as Therapeutic Targets for Anti-Cancer and Anti-Angiogenesis Treatments

By  

Current Signal Transduction Therapy, Vol. 4, Iss. 2, 2009-05 ,pp. : 130-143

Bentham Science Publishers

Access to resources Recommend Favorite

Divergence of P53, PTEN, PI3K, Akt and mTOR expression in tonsillar cancer

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 5, 2015-05 ,pp. : 636-643

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Dark Side of the Moon: The PI3K/PTEN/AKT Pathway in Colorectal Carcinoma

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 69-74

Karger

Access to resources Recommend Favorite

miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway

By            

International Journal of Molecular Medicine, Vol. 35, Iss. 5, 2015-01 ,pp. : 1301-1308

Spandidos Publications

Access to resources Recommend Favorite